On Feb 10, 2022 Indapta Therapeutics closed a Series A round and raised $50,000,000 from Leaps by Bayer, Lonza, Myeloma Investment Fund, RA Capital Management, […]
Series B – Arkuda Therapeutics
On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer […]
Series B – Ada Health
On Feb 10, 2022 Ada Health closed a Series B round and raised $30,000,000 from Bertelsmann, Farallon Capital Management, Red River West, featuring lead investors […]
Series B – MiNDCAFE
On Feb 10, 2022 MiNDCAFE closed a Series B round and raised $17,000,000 from E&Investment, Green Cross Holdings Corp, Hashed, Insight Equity Partners, K2 Investment, […]
Series A – QbDVision
On Feb 10, 2022 QbDVision closed a Series A round and raised $15,000,000 from Hudson Park Capital, Northpond Ventures, S3 Ventures, Wanxiang America Healthcare Investments […]
Series B – Arkuda Therapeutics
On Feb 10, 2022 Arkuda Therapeutics closed a Series B round and raised $64,000,000 from Atlas Venture, Cormorant Asset Management, Eli Lilly, Mission BioCapital, Pfizer […]
Series A – 1859
On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
Series A – Elicit Plant
On Feb 7, 2022 Elicit Plant closed a Series A round and raised €16,000,000 from AQUITI Gestion, Bpifrance, Crédit Agricole, European Circular Bioeconomy Fund, Région […]
Series B – Endeavor BioMedicines
On Feb 7, 2022 Endeavor BioMedicines closed a Series B round and raised $101,000,000 from Ally Bridge Group, Avidity Partners, Longitude Capital, Omega Funds, Perceptive […]
Series A – 1859
On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
